Diphtheria primary prevention

Revision as of 01:26, 10 October 2016 by Sara Mehrsefat (talk | contribs)
Jump to navigation Jump to search

Diphtheria Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Causes

Differentiating Diphtheria from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Electrocardiogram

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diphtheria primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diphtheria primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diphtheria primary prevention

CDC on Diphtheria primary prevention

Diphtheria primary prevention in the news

Blogs on Diphtheria primary prevention

Directions to Hospitals Treating Diphtheria

Risk calculators and risk factors for Diphtheria primary prevention

Overview

Primary Prevention

Vaccination

In the United States, there are four vaccines used to prevent diphtheria:

  • DTaP (given to children younger than 7 year)
  • Tdap (given to older children and adults)
  • DT ( given to children younger than 7 year)
  • Td (given to older children and adults)

Upper-case letters in these abbreviations denote full-strength doses of diphtheria (D) and tetanus (T) toxoids and pertussis (P) vaccine. Lower-case "d" and "p" denote reduced doses of diphtheria and pertussis used in the adolescent and adult formulations. The "a" in DTaP and Tdap stands for "acellular," meaning that the pertussis component contains only parts of the pertussis bacteria instead of the whole cell.

DTaP vaccine (Diphtheria, Tetanus, & acellular Pertussis)

Not get DTaP vaccine or should wait

  • Children who should not get DTaP vaccine or should wait include:
    • Children who are moderately or severely ill should usually wait until they recover before getting DTaP vaccine (minor illnesses, such as a cold, may be vaccinated)
    • Any child who had a life-threatening allergic reaction after a dose of DTaP should not get another dose
    • Any child who suffered a brain or nervous system disease within 7 days after a dose of DTaP should not get another dose.
  • Talk with your doctor if your child:
    • Had a seizure or collapsed after a dose of DTaP
    • Cried non-stop for 3 hours or more after a dose of DTaP
    • Had a fever over 105°F after a dose of DTaP

Some of these children should not get another dose of pertussis vaccine, but may get a vaccine without pertussis, called DT.

References



Template:WikiDoc Sources